Department of Neuropsychiatry, Ashikaga Red Cross Hospital, Ashikaga, Tochigi, 326-0843, Japan.
Department of Neuropsychiatry, Ashikaga Red Cross Hospital, Ashikaga, Tochigi, 326-0843, Japan; Department of Psychiatry, National Hospital Organization Shimofusa Psychiatric Medical Center, Chiba, 266-0007, Japan.
J Psychiatr Res. 2022 Jul;151:419-426. doi: 10.1016/j.jpsychires.2022.05.008. Epub 2022 May 13.
Although differential diagnosis between autoimmune encephalitis and schizophrenia spectrum disorders is crucial for a good outcome, the psychiatric symptoms that distinguish these two conditions have not been identified even though psychiatric symptoms are often the main manifestation of autoimmune encephalitis. Also, there are many situations in clinical psychiatry in which laboratory testing and imaging studies are not available. Because no comparative study of the psychiatric symptoms between these two conditions has been carried out, we explored diagnostically useful psychiatric symptoms in a retrospective case-control study.
We recruited 187 inpatients with first-episode psychosis who were admitted to our psychiatric unit and categorized them into two groups: the autoimmune encephalitis group (n = 10) and the schizophrenia spectrum disorders group (n = 177). Differences in the symptoms and signs between the two groups were investigated.
Schneider's first-rank symptoms (e.g., verbal commenting hallucinations and delusional self-experience) were observed only in the schizophrenia spectrum disorders group, whereas altered perception was found more frequently in the autoimmune encephalitis group. Functional status was worse in the autoimmune encephalitis group, and neurological and neuropsychological signs were revealed almost exclusively in this group. A history of mental illness was more frequently reported in the schizophrenia spectrum disorders group than in the autoimmune encephalitis group.
The psychiatric symptoms, i.e., Schneider's first-rank symptoms and altered perception, together with neurological and neuropsychological signs, functional status, and past history, may help clinicians accurately differentiate these two conditions among patients with first-episode psychosis.
尽管自身免疫性脑炎和精神分裂症谱系障碍的鉴别诊断对获得良好预后至关重要,但即使精神症状通常是自身免疫性脑炎的主要表现,也尚未确定区分这两种疾病的精神症状。此外,在临床精神病学中有许多情况下无法进行实验室检查和影像学研究。由于尚未对这两种疾病的精神症状进行比较研究,因此我们通过回顾性病例对照研究来探讨具有诊断价值的精神症状。
我们招募了 187 名首次出现精神病症状的住院患者,并将他们分为两组:自身免疫性脑炎组(n=10)和精神分裂症谱系障碍组(n=177)。调查两组之间症状和体征的差异。
精神分裂症谱系障碍组仅出现 Schneider 一级症状(例如言语评论性幻觉和妄想性自我体验),而自身免疫性脑炎组更常出现感知改变。自身免疫性脑炎组的功能状态更差,并且几乎仅在此组中发现神经系统和神经心理学体征。与自身免疫性脑炎组相比,精神分裂症谱系障碍组报告的既往精神病史更为常见。
精神症状,即 Schneider 一级症状和感知改变,以及神经系统和神经心理学体征、功能状态和既往病史,可能有助于临床医生在首次出现精神病的患者中准确地区分这两种疾病。